Covid-19 Products
- All
- News
- Videos
-
Key Points Of WHO Pandemic Agreement
The WHO Pandemic Agreement, an accord designed to address the mistakes made in handling COVID-19, is being submitted for adoption Tuesday at the World Health Assembly.
-
Instead of a Threat, Canva Sees AI as a Tailwind, Says Co-Founder Cameron Adams
Gadgets 360 spoke with Cameron Adams, Co-Founder and Chief Product Officer at Canva to better understand the intricacies of the design world, how the companies look at AI, and what is the larger vision behind it. Founded in 2013, the Sydney-based graphic designing platform has recently integrated a wide range of AI tools and launched a major enterp...
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Foxconn to Invest Over $1.5 Billion in India; Sent Chinese Engineers to Train Workers This Year: Reports
Apple supplier Foxconn will invest over $1.5 billion (roughly Rs. 12,500 crore) in India as the company looks to expand production of Apple's iPhone in the country, according to a report. The move comes a year after the Taiwanese firm's factories in China were severely impacted by the country's strict COVID-19 restrictions in 2022. The company also...
-
Xiaomi Quarterly Revenue Falls 18.9 Percent as Global Smartphone Demand Stalls
Xiaomi reported an 18.9 percent drop in quarterly revenue on Wednesday as consumer demand for smartphones remained weak even as the economy recovered from the COVID-19 pandemic.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Apple Partner Foxconn Seeking India’s Cooperation to Make EVs, Chips
Apple supplier Foxconn said on Saturday it was seeking cooperation in India in new areas like chips and electric vehicles (EVs) after a visit to the country by its chairman, Liu Young-way. Apple has been shifting production away from China after the country's strict COVID-19 restrictions disrupted the manufacturing of new-model iPhones and other de...
-
Apple Could Report Its First Decline in Quarterly Revenue in Nearly 4 Years, Say Analysts
Apple is expected to report its first decline in quarterly revenue in nearly four years after strict COVID-19 curbs in China rapped the economy and related protests upended iPhone production at its biggest supplier Foxconn. Investors will look for details on how Chief Executive Tim Cook is trying to bolster demand in a weak economy that has prompt...
-
iPhone Assembler Foxconn Replaces iPhone Business Chief After Tumultuous Year in China: Report
Foxconn has reportedly appointed Michael Chiang as the company's iPhone assembly business chief after a troubled year for the company in China. The company's plant in China's Zhengzhou city was heavily affected late last year after the country's COVID-19 curbs prompted thousands of workers to leave, followed by worker unrest and protests. Chiang wi...
-
Half of All iPhone Units to Be Assembled in India by 2027 as Apple Moves Production Out of China: Report
Apple reportedly plans to manufacture half of all iPhones in India by 2027. The COVID-19 pandemic and the ensuing limitations taught the firm that it couldn't keep all of its manufacturing plants in one country. Apple was significantly impacted by China's restrictions. After all, its partner Foxconn has a strong presence in the country. To reduce i...
-
Amid Covid Surge, China Says Medicines In "Adequate Supply"
Amid a rise in COVID-19 cases, the Chinese Foreign Ministry said that they have "expanded production capacity" of medical supplies amid reports of a shortage of fever and cold drugs medicines.
-
China Takes Over Medical Supplies Across Country Amid Covid Surge
China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases.
-
iPhone SE 4 Mass Production to Be Cancelled or Postponed Until 2024: Ming-Chi Kuo
Analyst Ming-Chi Kup claims that Apple could cancel or delay the mass production plans for iPhone SE 4 to 2024. The Cupertino company could choose to halt the development of new products to tackle the challenges posed by the global economic recession in 2023.
-
Apple Said to Plan to Move Some iPhone Production Out of China After Violent Protests at Foxconn Plant
Apple is reportedly accelerating its plans to move iPhone production out of China, to other countries like India and Vietnam. The Cupertino company is said to be looking to reduce its dependence on Taiwanese assemblers such as Foxconn. Last month, Foxconn's iPhone assembly plant in Zhengzhou was rocked by violent protests over a pay dispute, affect...
-
Key Points Of WHO Pandemic Agreement
The WHO Pandemic Agreement, an accord designed to address the mistakes made in handling COVID-19, is being submitted for adoption Tuesday at the World Health Assembly.
-
Instead of a Threat, Canva Sees AI as a Tailwind, Says Co-Founder Cameron Adams
Gadgets 360 spoke with Cameron Adams, Co-Founder and Chief Product Officer at Canva to better understand the intricacies of the design world, how the companies look at AI, and what is the larger vision behind it. Founded in 2013, the Sydney-based graphic designing platform has recently integrated a wide range of AI tools and launched a major enterp...
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Foxconn to Invest Over $1.5 Billion in India; Sent Chinese Engineers to Train Workers This Year: Reports
Apple supplier Foxconn will invest over $1.5 billion (roughly Rs. 12,500 crore) in India as the company looks to expand production of Apple's iPhone in the country, according to a report. The move comes a year after the Taiwanese firm's factories in China were severely impacted by the country's strict COVID-19 restrictions in 2022. The company also...
-
Xiaomi Quarterly Revenue Falls 18.9 Percent as Global Smartphone Demand Stalls
Xiaomi reported an 18.9 percent drop in quarterly revenue on Wednesday as consumer demand for smartphones remained weak even as the economy recovered from the COVID-19 pandemic.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Apple Partner Foxconn Seeking India’s Cooperation to Make EVs, Chips
Apple supplier Foxconn said on Saturday it was seeking cooperation in India in new areas like chips and electric vehicles (EVs) after a visit to the country by its chairman, Liu Young-way. Apple has been shifting production away from China after the country's strict COVID-19 restrictions disrupted the manufacturing of new-model iPhones and other de...
-
Apple Could Report Its First Decline in Quarterly Revenue in Nearly 4 Years, Say Analysts
Apple is expected to report its first decline in quarterly revenue in nearly four years after strict COVID-19 curbs in China rapped the economy and related protests upended iPhone production at its biggest supplier Foxconn. Investors will look for details on how Chief Executive Tim Cook is trying to bolster demand in a weak economy that has prompt...
-
iPhone Assembler Foxconn Replaces iPhone Business Chief After Tumultuous Year in China: Report
Foxconn has reportedly appointed Michael Chiang as the company's iPhone assembly business chief after a troubled year for the company in China. The company's plant in China's Zhengzhou city was heavily affected late last year after the country's COVID-19 curbs prompted thousands of workers to leave, followed by worker unrest and protests. Chiang wi...
-
Half of All iPhone Units to Be Assembled in India by 2027 as Apple Moves Production Out of China: Report
Apple reportedly plans to manufacture half of all iPhones in India by 2027. The COVID-19 pandemic and the ensuing limitations taught the firm that it couldn't keep all of its manufacturing plants in one country. Apple was significantly impacted by China's restrictions. After all, its partner Foxconn has a strong presence in the country. To reduce i...
-
Amid Covid Surge, China Says Medicines In "Adequate Supply"
Amid a rise in COVID-19 cases, the Chinese Foreign Ministry said that they have "expanded production capacity" of medical supplies amid reports of a shortage of fever and cold drugs medicines.
-
China Takes Over Medical Supplies Across Country Amid Covid Surge
China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases.
-
iPhone SE 4 Mass Production to Be Cancelled or Postponed Until 2024: Ming-Chi Kuo
Analyst Ming-Chi Kup claims that Apple could cancel or delay the mass production plans for iPhone SE 4 to 2024. The Cupertino company could choose to halt the development of new products to tackle the challenges posed by the global economic recession in 2023.
-
Apple Said to Plan to Move Some iPhone Production Out of China After Violent Protests at Foxconn Plant
Apple is reportedly accelerating its plans to move iPhone production out of China, to other countries like India and Vietnam. The Cupertino company is said to be looking to reduce its dependence on Taiwanese assemblers such as Foxconn. Last month, Foxconn's iPhone assembly plant in Zhengzhou was rocked by violent protests over a pay dispute, affect...
